Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Boston Scientific Corp (BSX) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 32,026,650
  • Shares Outstanding, K 1,360,740
  • Annual Sales, $ 7,477 M
  • Annual Income, $ -239 M
  • 36-Month Beta 1.09
  • Price/Sales 3.92
  • Price/Book 4.94

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.03 +13.27%
on 12/15/16
23.91 -0.38%
on 01/13/17
+2.48 (+11.62%)
since 12/13/16
3-Month
19.67 +21.10%
on 12/01/16
23.91 -0.38%
on 01/13/17
+0.67 (+2.89%)
since 10/13/16
52-Week
15.67 +52.01%
on 02/08/16
24.79 -3.91%
on 07/28/16
+6.27 (+35.73%)
since 01/13/16

Most Recent Stories

More News
Stock Market News for January 11, 2017

The Nasdaq registered its fourth record close in a row on Tuesday, thanks to gains in healthcare stocks

Joanna Engelke Joins Halloran Consulting Group as Managing Director

Halloran Consulting Group, a national consultancy to life science companies of all sizes, today announced that Joanna Engelke has joined the company as managing director and will work...

Cutera Names James A. Reinstein as its Next President and CEO

Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, announced the appointment of James A. Reinstein as its...

Greenberg Traurig Trial Victory Named Top Defense Verdict of 2016

Greenberg Traurig's trial win on behalf of C.R. Bard, Inc. was recognized as a "Top Defense Verdict of 2016" by Courtroom View Network (CVN). In February 2016, a team led by Shareholder Lori Cohen obtained...

Courtroom View Network Names Shook Verdict No. 1 Defense Win of 2016

Courtroom View Network (CVN), the industry leader focused on coverage of high-stakes, bet-the-company civil trials involving the nation's top trial attorneys, has named one of Shook, Hardy & Bacon's trial...

Flagship Pioneering Appoints David Epstein Executive Partner

Flagship Pioneering today announced the appointment of industry veteran David Epstein to serve in the newly created role of Executive Partner. Epstein will join as a strategic resource to the firm that...

Boston Scientific To Webcast Conference Call Discussing Fourth Quarter 2016 Financial Results And Announces 2017 Investor Day Business Review

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter ended December 31, 2016 on Thursday, February 2, 2017, at 8:00 a.m. EST.

Boston Scientific To Participate In 35th Annual J.P. Morgan Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 in San Francisco.

Boston Scientific Down on Risks; Innovations Raise Hope

On Dec 27 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX).

Cardiac Rhythm Management Devices Batteries Market to Worth US$518.4 Million by 2024: Improved Power Sources Ensure Swift Uptake, says TMR

Transparency Market Research states that the competitive landscape in the Global Cardiac Rhythm Management Devices Batteries Market is mildly fragmented. The leading players such as Medtronic, Boston Scientific...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary...

See More

Support & Resistance

2nd Resistance Point 24.19
1st Resistance Point 24.00
Last Price 23.82
1st Support Level 23.54
2nd Support Level 23.27

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.